EE464 The Cost-Effectiveness of Subcutaneous Semaglutide 2.4MG Injection in the Management of Obesity in Canada Using the Core Obesity Model
- Resource Type
- Abstract
- Source
- In
Value in Health July 2022 25(7) Supplement:S426-S426 - Subject
- Language
- ISSN
- 1098-3015